Results 181 to 190 of about 19,609 (207)

[Urease activity in Cryptococcus neoformans and Cryptococcus gattii].

Revista iberoamericana de micologia, 2008
Urease is an enzyme considered one of the main virulence factors in Cryptococcus neoformans. Quantitative differences in urease production between C. neoformans and the new species Cryptococcus gattii have not been so far documented. Using a standardized method, 25 isolates of C. neoformans and 19 of C.
Josep M, Torres-Rodríguez, Eidi, Alvarado-Ramírez, Ricardo, Gutiérrez-Gallego   +2 more
openaire   +1 more source

MSG07: An International Cohort Study Comparing Epidemiology and Outcomes of Patients With Cryptococcus neoformans or Cryptococcus gattii Infections

Clinical Infectious Diseases, 2021
Eleni Galanis, John Baddley, Tania Sorrell   +2 more
exaly  

Assessing exposure to Cryptococcus gattii

2010
Cryptococcus gattii is an encapsulated basidomycetous yeast that is capable of causing cryptococcosis in humans and animals. The disease caused by C. gattii frequently begins with pneumonia which in some cases can disseminate into fatal form of meningitis.
openaire   +1 more source

Environmental Status of Cryptococcus neoformans and Cryptococcus gattii in Colombia

Journal of Fungi (Basel, Switzerland), 2021
Maribel Forero-Castro, Patricia Escandon, Zilpa Adriana Sanchez Quitian   +2 more
exaly  

Cryptococcus gattii

Clinical Microbiology Newsletter, 2009
openaire   +1 more source

Cryptococcus gattii

2012
Adeel Abbasi, Francis DeRoos, José Artur Paiva, J.M. Pereira, Brian G. Harbrecht, Donald P. Levine, Patricia D. Brown, Lara Wijayasiri, Andrew Rhodes, Maurizio Cecconi, Jonathan R. Egan, Marino S. Festa, Chadwick D. Miller, Daniel W. Entrikin, W. Gregory Hundley, James McCord, Giorgio Della Rocca, Maria Gabriella Costa, Nima Majlesi, Diane P. Calello, Richard D. Shih, Dominic W. K. Spray, Jonathan R. Egan, Marino S. Festa, Raghu R. Seethala, Benjamin S. Abella, Claudio Ronco, Mikko Haapio, Nagesh S. Anavekar, Andrew A. House, Rinaldo Bellomo, Andrew M. Morris, Andrew M. Morris, Scott E. Bell, Kathryn M. Beauchamp, Sarah E. Pinski, Arianne Boylan, Jens-Peter Witt, Todd F. VanderHeiden, Philip F. Stahel, Gorazd Voga, José Rodolfo Rocco, Daniel B. Craig, Kathryn M. Beauchamp, Suzanne M. Shepherd, William H. Shoff, Samuel Waller, Kathryn M. Beauchamp, Sonia Labeau, Dominique Vandijck, Stijn Blot, John Tobias Nagurney, Donald D. Trunkey, John C. Mayberry, Christopher M. Watson, Robert G. Sawyer, Laura J. Moore, Ares Krishna Menon, Rüdiger Autschbach, Andrew M. Morris, Werner Baulig, Donat R. Spahn, Michael T. Ganter, Jeffry L. Kashuk, Judd E. Hollander, Julie P. Chou, Tom Lim, Andrew G. Lee, Christopher H. Mody, Lewis J. Kaplan, Roselle Crombie, Gina Luckianow, Derrick Sun, Kathryn M. Beauchamp, Jonathan R. Egan, Marino S. Festa, John H. Burton, Eric A. J. Hoste, Scott E. Bell, Kathryn M. Beauchamp, Zhongping Huang, William R. Clark, Claudio Ronco, Judd E. Hollander, Harold Litt, Jeremy Cordingley, Thomas J. Marrie, Lucido L. Ponce, Claudia S. Robertson, Carla Nester, Patrick D. Brophy, Anders Kallner, Brent P. Goodman, Julie P. Chou, Tom Lim, Andrew G. Lee, Christopher H. Mody, Richard D. Shih, Oliver L. Hung, Stefan Herget-Rosenthal   +99 more
openaire   +1 more source

Cryptococcus Species Other Than Cryptococcus neoformans and Cryptococcus gattii: Are They Clinically Significant?

Open Forum Infectious Diseases, 2020
Raymund Razonable, Edison Cano, Zachary A Yetmar   +2 more
exaly  

Virulence profiling of Cryptococcus gattii isolates in China: insights from a multi-center study

Microbiology Spectrum, 2023
Xuelei Zang, Linqi Wang, Xinying Xue
exaly  

Development of a Real-Time PCR Assay to Identify and Distinguish between Cryptococcus neoformans and Cryptococcus gattii Species Complexes

Journal of Fungi (Basel, Switzerland), 2022
Catriona L Halliday, Sharon Chen
exaly  

Promiscuous mitochondria in Cryptococcus gattii

2009
Cryptococcus gattii is a primary pathogenic basidiomycetous yeast comprising four genotypic groups. Here we present data on two mitochondrial loci (MtLrRNA and ATP6). Two of the genotypic groups, namely amplified fragment length polymorphism (AFLP)5/VGIII and AFLP6/VGII, formed monophyletic lineages.
Bovers,Marjan, Hagen, Ferry, Kuramae,Eiko E, Boekhout,Teun, MMB Medische Staf, Infection & Immunity   +5 more
openaire   +1 more source